WallStreetZenWallStreetZen

NASDAQ: TARS
Tarsus Pharmaceuticals Inc Stock Ownership - Who owns Tarsus Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tarsus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bobak R. AzamianPresidentCEO and Board Chair2026-06-174,582$61.24
$280.60kSell
Bobak R. AzamianPresidentCEO and Board Chair2026-06-175,418$61.81
$334.89kSell
Jeffrey S. FarrowChief Financial Officer and Chief Strategy Officer2026-06-1614,396$60.95
$877.44kSell
William J. Phd LinkDirector2026-06-1510,572$61.97
$655.15kSell
William J. Phd LinkDirector2026-06-151,928$62.94
$121.35kSell
Katherine GoodrichDirector2026-06-152,954$62.08
$183.38kSell
Seshadri NeervannanChief Operating Officer2026-03-202,989$66.75
$199.52kSell
Bobak R. AzamianPresidentCEO and Board Chair2026-03-1911,964$67.00
$801.59kSell
Jeffrey S. FarrowChief Financial Officer and Chief Strategy Officer2026-03-192,186$67.00
$146.46kSell
Elizabeth Yeu LinChief Medical Officer2026-03-19390$67.00
$26.13kSell

1 of 5

TARS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TARS insiders and whales buy or sell their stock.

TARS Shareholders

What type of owners hold Tarsus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Capital IX LLC13.28%5,714,036$340.21MInsider
Deep Track Capital LP8.37%3,600,000$214.34MInstitution
Blackrock Inc8.26%3,552,612$211.52MInstitution
Rtw Investments LP7.78%3,346,025$199.22MInstitution
Paradigm Biocapital Advisors LP5.96%2,562,154$152.55MInstitution
Janus Henderson Group PLC5.21%2,240,963$133.43MInstitution
Rtw Investments LP4.68%2,013,601$119.89MInsider
Horowitz Limited Partnership VIII4.62%1,987,105$118.31MInsider
Jason E. Tester4.53%1,949,331$116.06MInsider
Morgan Stanley4.52%1,944,272$115.76MInstitution

1 of 3

TARS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TARS73.41%26.59%Net SellingNet Selling
IMNM96.16%3.84%Net SellingNet Selling
TRVI43.91%56.09%Net Buying
KOD73.18%26.82%Net BuyingNet Buying
BEAM86.62%13.38%Net SellingNet Selling
View Top Biotech Stocks

Tarsus Pharmaceuticals Stock Ownership FAQ

Who owns Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals (NASDAQ: TARS) is owned by 104.92% institutional shareholders, 38.00% Tarsus Pharmaceuticals insiders, and 0.00% retail investors. Vivo Capital IX LLC is the largest individual Tarsus Pharmaceuticals shareholder, owning 5.71M shares representing 13.28% of the company. Vivo Capital IX LLC's Tarsus Pharmaceuticals shares are currently valued at $337.36M.

If you're new to stock investing, here's how to buy Tarsus Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.